Eukaryotic translation termination factor gene (ETF1/eRF1) maps at D5S500 in a commonly deleted region of chromosome 5q31 in malignant myeloid diseases

被引:7
作者
Guenet, L
Henry, C
Toutain, B
Dubourg, C
Le Gall, JY
David, V
Le Treut, A
机构
[1] Fac Med, Dept Biochim & Biol Mol, Biochim Lab A, F-35043 Rennes, France
[2] Fac Med, CNRS, UPR41, F-35043 Rennes, France
[3] CHRU Pontchaillou, Serv Cytogenet & Biol Cellulaire, Rennes, France
来源
CYTOGENETICS AND CELL GENETICS | 2000年 / 88卷 / 1-2期
关键词
D O I
10.1159/000015491
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The human genome contains four ETE1 (eukaryotic translation termination factor 1) homologous sequences, Idealized on chromosomes 5, 6, 7 and X, and corresponding to a functional gene an chromosome 5 and three processed pseudogenes on the other chromosomes. ETF1 genomic or cDNA probes were mapped by fluorescence in situ hybridization to 5q31, 6p21, 7q11 and Xp11.4-->p11.1. A microsatellite marker (D5S500) was identified in intron 7 of the functional ETF1 gene providing its exact position in the 5q31 band. Thus, the ETF1 gene is located in a 5q region which contains unidentified genes responsible for genetic or malignant disorders, and it might be considered as a candidate gene involved in the pathogenesis of these diseases. Copyright (C) 2000 S.Karger AG, Basel.
引用
收藏
页码:82 / 86
页数:5
相关论文
共 32 条
[1]   Gapped BLAST and PSI-BLAST: a new generation of protein database search programs [J].
Altschul, SF ;
Madden, TL ;
Schaffer, AA ;
Zhang, JH ;
Zhang, Z ;
Miller, W ;
Lipman, DJ .
NUCLEIC ACIDS RESEARCH, 1997, 25 (17) :3389-3402
[2]   Deletion 5q31 in patients with stable, melphalan-treated multiple myeloma [J].
Amiel, A ;
Fridman, K ;
Elis, A ;
Gaber, E ;
Manor, Y ;
Fejgin, M ;
Lishner, M .
CANCER GENETICS AND CYTOGENETICS, 1999, 113 (01) :45-48
[3]   Use of a CEPH meiotic breakpoint panel to refine the locus of limb-girdle muscular dystrophy type 1A (LGMD1A) to a 2-Mb interval on 5q31 [J].
Bartoloni, L ;
Horrigan, SK ;
Viles, KD ;
Gilchrist, JM ;
Stajich, JM ;
Vance, JM ;
Yamaoka, LH ;
Pericak-Vance, MA ;
Westbrook, CA ;
Speer, MC .
GENOMICS, 1998, 54 (02) :250-255
[4]   A HUMAN HOMOLOG TO THE YEAST OMNIPOTENT SUPPRESSOR-45 MAPS 100 KB CENTROMERIC TO HLA-A [J].
CHAUVEL, B ;
DORVAL, I ;
FERGELOT, P ;
PICHON, L ;
GIFFON, T ;
GICQUEL, I ;
LEGALL, JY ;
DAVID, V .
IMMUNOGENETICS, 1995, 41 (06) :380-382
[5]  
CHUMAKOV IM, 1995, NATURE, V377, P175
[6]   Eukaryotic release factor 1 (eRF1) abolishes readthrough and competes with suppressor tRNAs at all three termination codons in messenger RNA [J].
Drugeon, G ;
JeanJean, O ;
Frolova, L ;
LeGoff, X ;
Philippe, M ;
Kisselev, L ;
Haenni, AL .
NUCLEIC ACIDS RESEARCH, 1997, 25 (12) :2254-2258
[7]  
ELKAHLOUN A, 1993, HUM MOL GENET, V2, P55
[8]   PHYSICAL MAPPING OF THE MINIMAL REGION OF LOSS IN 5Q-CHROMOSOME [J].
FAIRMAN, J ;
CHUMAKOV, I ;
CHINAULT, AC ;
NOWELL, PC ;
NAGARAJAN, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7406-7410
[9]   Vocal cord and pharyngeal weakness with autosomal dominant distal myopathy:: Clinical description and gene localization to 5q31 [J].
Feit, H ;
Silbergleit, A ;
Schneider, LB ;
Gutierrez, JA ;
Fitoussi, RP ;
Réyès, C ;
Rouleau, GA ;
Brais, B ;
Jackson, CE ;
Beckmann, JS ;
Seboun, E .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (06) :1732-1742
[10]   A HIGHLY CONSERVED EUKARYOTIC PROTEIN FAMILY POSSESSING PROPERTIES OF POLYPEPTIDE-CHAIN RELEASE FACTOR [J].
FROLOVA, L ;
LEGOFF, X ;
RASMUSSEN, HH ;
CHEPEREGIN, S ;
DRUGEON, G ;
KRESS, M ;
ARMAN, I ;
HAENNI, AL ;
CELIS, JE ;
PHILIPPE, M ;
JUSTESEN, J ;
KISSELEV, L .
NATURE, 1994, 372 (6507) :701-703